Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02125773 · ClinicalTrials.gov registry record · NA
Pre-exposure Prophylaxis Accessibility Research and Evaluation 2
A NA study of PrEP Uptake and HIV Seronegativity, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT02125773 is a NA study of PrEP Uptake and HIV Seronegativity that has completed, run by University of California, San Diego. The registered enrollment target is 150 participants, below the 405-participant average among 3 other PrEP Uptake trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02125773, a NA study of PrEP Uptake and HIV Seronegativity, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a controlled, un-blinded, two-arm, randomized (1:1) clinical trial to determine if providing high-risk subjects with a calculated risk score changes the likelihood of pre-exposure prophylaxis (PrEP) uptake.
Conditions Studied
Interventions
- BEHAVIORAL Informed Risk Score
Study Locations (1)
California
- University of California, San Diego - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2014-02-19 |
| Est. Completion | 2019-11-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02125773
The ClinicalTrials.gov registry entry for NCT02125773 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 405-participant average among 3 other PrEP Uptake trials with a reported enrollment target (63% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with PrEP Uptake appearing as the primary indexed condition, and to 1 intervention - of which Informed Risk Score is the first listed.
NCT02125773 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02125773 about?
NCT02125773 is a clinical study titled "Pre-exposure Prophylaxis Accessibility Research and Evaluation 2". This study is a controlled, un-blinded, two-arm, randomized (1:1) clinical trial to determine if providing high-risk subjects with a calculated risk score changes the likelihood of pre-exposure prophylaxis (PrEP) uptake.
What is the current status of trial NCT02125773?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2014-02-19. Estimated completion is 2019-11-08.
What conditions does trial NCT02125773 study?
This clinical trial studies the following conditions: PrEP Uptake, HIV Seronegativity.
What interventions are being tested in trial NCT02125773?
The interventions under investigation include: Informed Risk Score (BEHAVIORAL).
Who is sponsoring clinical trial NCT02125773?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02125773 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PrEP Uptake
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
PrOTECT AL: PrEP Optimization Through Enhanced Continuum Tracking
RECRUITING · NA
-
P3 Trial: Estimating the Impact of a Multilevel, Multicomponent Intervention to Increase Uptake of HIV Testing and Biomedical HIV Prevention Among African-American/Black Gay, Bisexual, and Same-gender Loving Men
RECRUITING · NA
-
PrEP Optimization Among Women to Enhance Retention and Uptake
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.